781أداة الفرز المتكاملة المشتركة بين الوكالات: السن 12 سنة فأكثر (اعدتها منظمة الصحة العالمية واللجنة الدولية للصليب الأحمر ومنظمة اطباء بلا حدود)Technical documents · July 14, 2025
782Air quality legislation and implications for health: technical briefTechnical Documents · July 14, 2025
783The synergies of heat stress and air pollution and its health impacts: technical briefTechnical documents · July 14, 2025
785مقدمة عن أداة الفرز المتكاملة المشتركة بين الوكالات: تحديث نيسان/أبريل 2020Technical documents · July 14, 2025
787Evaluation of public health analytics: workshop report, 8-9 October 2024Technical documents · July 13, 2025
788Agriculture: sectoral solutions for air pollution and health: technical briefTechnical documents · July 13, 2025
789Country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus programmes: web annex B: landscape findings and recommendationsTechnical documents · July 13, 2025
790Open waste burning: sectoral solutions for air pollution and health: technical briefTechnical Documents · July 13, 2025
791Country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus programmes: web annex A: scoping review of strategies and missed opportunitiesTechnical documents · July 13, 2025
792Recommendations on the delivery of health services for the prevention and care of sexually transmitted infections: web annexes: evidence-to-decision frameworks and systematic reviews for the delivery of health services for the prevention and care of sexually transmitted infectionsTechnical Documents · July 10, 2025
793Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis: web annex F: lenacapavir-associated drug resistance: implications for scaling up long-acting PrEPTechnical Documents · July 10, 2025
794Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis (PrEP): web annex C: systematic review of values and preferences for lenacapavir as pre-exposure prophylaxis and other forms of long-acting injectable PrEPTechnical Documents · July 10, 2025
795Overview of WHO recommendations on HIV and sexually transmitted infection testing, prevention, treatment, care and service deliveryTechnical Documents · July 10, 2025
796Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis: web annex A: declarations of interest for the Guideline Development Group and external peer reviewersTechnical Documents · July 10, 2025
797WHO operational handbook on tuberculosis: module 3: diagnosis: web annex B: WHO critical concentrations for pretomanid and cycloserine: systematic review and technical advisory group reportsTechnical Documents · July 10, 2025
798Inclusion of antimicrobial resistance in training programmes for community health workers: technical briefTechnical Documents · July 10, 2025
799Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis: web annex B: safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic reviewTechnical Documents · July 10, 2025
800Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis: web annex D: should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP?Technical Documents · July 10, 2025